Cancer News and Research

Latest Cancer News and Research

Research to determine whether long term use of organophosphate insecticides and other pesticides leads to an increased risk of cancer

Researchers from Monash University, Australia will study the long-term health effects of pesticide use focusing on fruit growers in the Goulburn Valley.

2 Aug 2004

New approach to cancer vaccines may eradicate skin cancer tumors

Mayo Clinic and British researchers have developed a new approach to cancer vaccines that purposely kills healthy skin cells to target the immune system against tumors. The new approach has eradicated skin cancer tumors in mice.

2 Aug 2004

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.

2 Aug 2004

Hormone that is important in the control of blood pressure may also inhibit the growth of lung cancer cells

Their studies found that angiotensin-(1-7) significantly slows the growth of three different types of human lung cancer cells in the laboratory. "Our experiments provide the first evidence that angiotensin-(1-7) inhibits the proliferation of human lung cancer cells," they said.

2 Aug 2004

Identification of PIK3CA as an oncogene associated with brain cancers opens the door to new screening processes

Hotspots in two areas of a gene that encodes a specific signaling enzyme, or kinase, are vulnerable to a variety of mutations found in five types of brain cancers, according to a report published in the August 1 issue of the journal Cancer Research.

2 Aug 2004

Miniature spectroscopic instruments and software to look at changes that occur within the cells and tissue of the brain

When molecules in cells are stimulated by light, they respond by becoming excited and re-emitting light of varying colors (fluorescence) that can be captured and measured by highly sensitive optical equipment.

2 Aug 2004

The p53 transcription factor plays a vital role in preventing cancer onset

Researchers at the Uppsala Branch of the Ludwig Institute for Cancer Research have discovered that the transcription factor Yin Yang 1 (YY1) is a novel regulator of the tumor suppressor p53, which is inactivated in at least half of all human cancers.

2 Aug 2004

Cancer detection kit, which fuses molecular diagnostics with nanotechnology

Acrongenomics Inc. has introduced a revolutionary design of its nanobiotechnology product, the Neo-EpCAM(TM) cancer detection kit, which fuses molecular diagnostics with nanotechnology.

29 Jul 2004

Australian Commonwealth and Queensland Governments sign public health funding agreement

The Commonwealth and the Queensland Government have renewed their commitment to public health in Queensland by agreeing to sign a further five year Public Health Outcome Funding Agreement for the period 2004-09.

29 Jul 2004

New surgical technique for larynx reconstruction

Professor Pierre Delaere (Otorhinolaryngology Department, K.U.Leuven) has in the past decade developed a new surgical technique for larynx reconstruction.

29 Jul 2004

Health Canada is advising consumers not to use products containing Aristolochic Acid

Health Canada is advising consumers not to use products containing Aristolochic Acid, a naturally occurring toxin that can cause cancer, mutations in human cells, and end-stage kidney failure.

29 Jul 2004

Research to develop ways to inhibit head and neck cancers, the fifth most common cancer worldwide

A University of Queensland researcher has been awarded $850,000 by one of Australia’s largest private, charitable, medical foundations to develop ways to inhibit head and neck cancers, the fifth most common cancer worldwide.

29 Jul 2004

Drug to fight virus from the herpes family in transplant patients moves forward in trials

A drug once considered for cancer chemotherapy is advancing in clinical trials to test its effectiveness in fighting a virus from the herpes family that threatens transplant patients.

29 Jul 2004

Brewing expert examines health potential of beer

Beer is often dismissed as a mere pleasant libation, at best, or an evil abomination, at worst. Few people stop to consider that the age-old beverage "is very much a food" with genuine benefits when consumed intelligently, writes a UC Davis brewing scientist.

29 Jul 2004

15 new NHS hospital developments worth more than £4 billion

The announcement will bring investment in new NHS hospitals to more than £16 billion since 1997. The NHS is already well on course to meet the NHS Plan target of 100 new hospital schemes open to patients by 2010. More than 40 are already built and operational.

29 Jul 2004

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Feeling sick can be "all in the head" for people with inflammatory disorders or for those receiving immunotherapy, say Robert Dantzer and Keith Kelley, professors in the department of animal sciences at the University of Illinois at Urbana-Champaign.

29 Jul 2004

Tool that enables women with breast cancer to choose their own course of treatment

McMaster University cancer researcher, Tim Whelan, a radiation oncologist with the Juravinski Cancer Centre, has developed a tool that enables women with breast cancer to choose their own course of treatment.

29 Jul 2004

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.

29 Jul 2004

Corus Pharma selected as a biotech company to watch

Corus Pharma announced yesterday that it has been selected as a member of FierceBiotech's annual "The Fierce 15." FierceBiotech Editor-in-Chief John D. Carroll observed "We applaud Corus' ongoing commitment to increasing the quality of life for people living with cystic fibrosis."

29 Jul 2004

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

High-risk prostate cancer patients who undergo a combination of hormonal therapy, radioactive seed implant (also called brachytherapy) and external beam radiation therapy are shown to have an increased chance of cancer cure

29 Jul 2004

Cancer News and Research

Latest Cancer News and Research

Research to determine whether long term use of organophosphate insecticides and other pesticides leads to an increased risk of cancer

New approach to cancer vaccines may eradicate skin cancer tumors

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Hormone that is important in the control of blood pressure may also inhibit the growth of lung cancer cells

Identification of PIK3CA as an oncogene associated with brain cancers opens the door to new screening processes

Miniature spectroscopic instruments and software to look at changes that occur within the cells and tissue of the brain

The p53 transcription factor plays a vital role in preventing cancer onset

Cancer detection kit, which fuses molecular diagnostics with nanotechnology

Australian Commonwealth and Queensland Governments sign public health funding agreement

New surgical technique for larynx reconstruction

Health Canada is advising consumers not to use products containing Aristolochic Acid

Research to develop ways to inhibit head and neck cancers, the fifth most common cancer worldwide

Drug to fight virus from the herpes family in transplant patients moves forward in trials

Brewing expert examines health potential of beer

15 new NHS hospital developments worth more than £4 billion

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Tool that enables women with breast cancer to choose their own course of treatment

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Corus Pharma selected as a biotech company to watch

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

Understanding the DNA Damage Response in Innate Immunity eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in